Lidocaine Patches Market - Size, Share, Outlook, and Forecast till 2026

Lidocaine is an analgesic used in a variety of administering forms such as intravenous, spray, and patches. Lidocaine patches are commonly used as a non-invasive method of treatment to relieve pain from symptoms of post-herpetic neuralgia and chronic back pain. Lidocaine is generally mixed with small amounts of adrenaline to allow for larger doses for numbing, decrease bleeding, and prolong the numbing effect.
Lidocaine patches are a form of local anesthesia, which often helps relieve the burning, stabbing pains, or aches that persist after shingles infections, which last for months up to years. The application of these patches is to stop nerves from delivering pain signals. Growing incidence of herpes neuralgia in turn, is expected to boost growth of the lidocaine patches market size.

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/195633

Furthermore, rising urbanization and increasing employed population that is perform desk work for prolong hours is increasing the prevalence of chronic back pain. Lidocaine patch 5% (Lidoderm), is prescribed by physicians as a targeted peripheral analgesic for chronic pain. This in turn, is expected to boost demand for lidocaine patches, further boosting growth of the lidocaine market, globally.
The ease usability of these patches that requires the solely the protective liner to be removed, followed by applying on to healthy, normal skin area that is most painful, is responsible for increasing adoption of lidocaine patches. Moreover, some patients do not require further medication to subside the pain symptoms due to the high effectiveness of these patches. These factors in turn, are driving growth of the lidocaine market.

Get Best Discount On This Report: https://www.worldwidemarketreports.com/discount/195633

However, when used on broken or irritated skin, the patch would lead to further skin damage. Some patients experience redness, swelling, blisters, or changes in skin color at the site of application due to application of this patch. This poses as a factor hampering growth of the lidocaine market.

Sorrento Therapeutics—a global biotechnology company—announced resubmission of a New Drug Application (NDA) seeking approval for ZTlido (lidocaine patch 1.8%) for the relief of pain associated with post-herpetic neuralgia, in 2017. ZTlido delivers bioequivalent levels of lidocaine to Lidoderm (lidocaine patch 5%) and Versatis (lidocaine medicated plaster 5%), which is safer for children and pets and reduces drug waste.

Hisamitsu America—a division of Hisamitsu Pharmaceutical Co., Inc.—announced the launch of Lidocaine Plus product line with the introduction of the Salonpas® Lidocaine Plus Pain Relieving Cream and the Salonpas® Lidocaine Plus Pain Relieving Liquid to its unscented Salonpas® Lidocaine 4% Pain Relieving Patch product segment for lidocaine.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com

This release was published on openPR.